Health-related quality of life of HIV-infected intravenous drug users

International Journal of STD and AIDS

Volumn 24, Issue 11, 2013, Pages 867-874

  Surah, S ^a   Adams, R ^a   Townsend, L ^a   Reynolds, I ^a   Kinahan, J C ^b   Keating, S ^a,b   Mulcahy, F ^a   Keenan, E ^b   Barry, M ^a   Lyons, F ^a  

^a ST JAMES S HOSPITAL   (Ireland)

^b Trinity Court   (Ireland)

Author keywords

AIDS; antiretroviral therapy; anxiety; depression; health related quality of life; HIV; injecting drug use; viral disease

Indexed keywords

ADULT; ANXIETY; ARTICLE; CD4 LYMPHOCYTE COUNT; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DEPRESSION; DRUG MISUSE; EMPLOYMENT STATUS; EUROQOL 5D; FEMALE; HEPATITIS C; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INTRAVENOUS DRUG ABUSE; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; MALE; MIXED INFECTION; MOOD DISORDER; NAMED INVENTORIES, QUESTIONNAIRES AND RATING SCALES; OUTPATIENT CARE; PRIORITY JOURNAL; QUALITY OF LIFE; QUESTIONNAIRE; SHORT FORM 36; SHORT FORM 6D; VIRUS LOAD;

EID: 84887372775     PISSN: 09564624     EISSN: None     Source Type: Journal    
DOI: 10.1177/0956462413486454     Document Type: Article

References (34)

1. Palella FJ,Delaney KM,Moorman AC,et al.Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators.New Eng J Med. 1998;338:853-860.
2. Fleming CA,Christiansen D,Nunes D,et al.Health-related quality of life of patients with HIV disease: impact of hepatitis C coinfection.Clin Infect Dis. 2004;38:572-578.
3. Miners AH,Sabin CA,Mocroft A,et al.Health-related quality of life in individuals infected with HIV in the era of HAART.HIV Clin Trial. 2001;2:484-492.
4. Braitstein P,Montessori V,Chan K,et al.Quality of life, depression and fatigue among persons co-infected with HIV and hepatitis C: outcomes from a population-based cohort.AIDS Care. 2005;17:505-515.
5. Briongos Figuero L,Bachiller Luque P,Palacios Martin T,et al.Assessment of factors influencing health-related quality of life in HIV-infected patients.HIV Med. 2010;12:22-30.
6. Korthius KP,Zephyrin LC,Feleishman JA,et al.Health-related quality of life in HIV-infected patients: the role of substance use.AIDS Pat Care STD. 2008;22:859-867.
7. Hays RD,Cunningham WE,Sherbourne CD,et al.Health-related quality of life in patients with human immunodeficiency virus infection in the United States: results from the HIV Cost and Services Utilization Study.Am J Med. 2000;108:714-722.
8. Jelsma J,Maclean E,Hughes J,et al.An investigation into the health-related quality of life of individuals living with HIV who are receiving HAART.AIDS Care. 2005;17:579-588.
9. Delate T,Coons SJ.The use of 2 health-related quality-of-life measures in a sample of persons infected with human immunodeficiency virus.Clin Infect Dis. 2001;32:E47-E52.
10. Gill CJ,Griffith JL,Jacobson D,et al.Relationship of HIV viral loads, CD4 counts, and HAART use to health-related quality of life.J Acquir Immune Defic Syndr. 2002;30:485-492.
11. Kauf TL,Roskell N,Shearer A,et al.A predictive model of health state utilities for HIV patients in the modern era of highly active antiretroviral therapy.Value Health. 2008;11:1144-1153.
12. Mathews WC,May S.EuroQol (EQ-5D) measure of quality of life predicts mortality, emergency department utilization, and hospital discharge rates in HIV-infected adults under care.Health Qual Life Outcomes. 2007;5:5-5.
13. Altice FL,Kamarulzaman A,Soriano VV,et al.Treatment of medical, psychiatric, and substance-use comorbidities in people infected with HIV who use drugs.Lancet. 2010;376:367-87.
14. Clarke S,Delamere S,McCullough L,et al.Assessing limiting factors to the acceptance of antiretroviral therapy in a large cohort of injecting drug users.HIV Med. 2003;4:33-37.
15. Brazier J,Roberts J,Deverill M.The estimation of a preference-based measure of health from the SF-36.J Health Econ. 2002;21:271-292.
16. EQ-5D: a standardised instrument for use as a measure of health outcome [online], http://www.euroqol.org (accessed 2012).
17. Zigmond AS,Snaith RP.The hospital anxiety and depression scale.Acta Psychiatr Scand. 1983;67:361-370.
18. Bjelland I,Dahl AA,Haug TT,et al.The validity of the Hospital Anxiety and Depression Scale.An updated literature review. J Psychosom Res. 2002;52:69-77.
19. Marsden J,Farrell M,Bradbury C,et al.Development of the treatment outcomes profile.Addiction. 2008;103:1450-1460.
20. Adams R,Walsh C,Veale D,et al.Understanding the relationship between the EQ-5D, SF-6D, HAQ and disease activity in inflammatory arthritis.Pharmacoeconomics. 2010;28:477-487.
21. Dolan P,Gudex C,Kind P,et al.The time trade-off method: results from a general population study.Health Econ. 1996;5:141-154.
22. Savard J,Laberge B,Gauthier JG,et al.Evaluating anxiety and depression in HIV-infected patients.J Pers Assess. 1998;71:349-367.
23. Williams I, Churchill D, Anderson J,et al.BHIVA guidelines for the treatment of HIV-1positive adults with antiretroviral therapy, http://www.bhiva.org/TreatmentofHIV1_2012.aspx (2012, accessed 2012).
24. Reiss P, Battegay M, Clumeck N,et al.European Guidelines for the Treatment of HIV Infected adults in Europe, version 6, http://www.europeanaidsclinicalsociety.org/images/stories/EACS-Pdf/EACSGuidelines-v6.0-English.pdf (2011, accessed 20 December 2012).
25. HSE. Public information: Your Health: Alcohol, http://www.hse.ie/eng/services/healthpromotion/alcohol/ (2011, accessed 2011).
26. Longworth L,Bryan S.An empirical comparison of EQ-5D and SF-6D in liver transplant patients.Health Econ. 2003;12:1061-1067.
27. Dan AA,Kallman JB,Srivastava R,et al.Impact of chronic liver disease and cirrhosis on health utilities using SF-6D and the health utility index.Liver Transpl. 2008;14:321-326.
28. Stavem K,Froland SS,Hellum KB.Comparison of preference-based utilities of the 15D, EQ-5D and SF-6D in patients with HIV/AIDS.Qual Life Res. 2005;14:971-980.
29. Arpinelli F,Visona G,Bruno R,et al.Health-related quality of life in asymptomatic patients with HIV. Evaluation of the SF-36 health survey in Italian patients.Pharmacoeconomics. 2000;18:63-72.
30. Heslin KC,Stein JA,Heinzerling KG,et al.Clinical correlates of health-related quality of life among opioid-dependent patients.Qual Life Res. 2011;20:1205-1213.
31. Bing EG,Burnam MA,Longshore D,et al.Psychiatric disorders and drug use among human immunodeficiency virus-infected adults in the United States.Arch Gen Psychiatry. 2001;58:721-728.
32. Sherbourne CD,Hays RD,Fleishman JA,et al.Impact of psychiatric conditions on health-related quality of life in persons with HIV infection.Am J Psychiatry. 2000;157:248-254.
33. Mrus JM,Sherman KE,Leonard AC,et al.Health values of patients coinfected with HIV/hepatitis C: are two viruses worse than one?.Med Care. 2006;44:158-166.
34. Johnson JA,Luo N,Shaw JW,et al.Valuations of EQ-5D health states: are the United States and United Kingdom different?.Med Care. 2005;43:221-228.